Health Catalyst, Inc - Common stock (HCAT)

1.6800
+0.0600 (3.70%)
NASDAQ · Last Trade: Mar 3rd, 12:04 AM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close1.620
Open1.590
Bid1.610
Ask1.850
Day's Range1.560 - 1.740
52 Week Range1.560 - 5.062
Volume1,536,132
Market Cap78.29M
PE Ratio (TTM)-1.057
EPS (TTM)-1.6
Dividend & YieldN/A (N/A)
1 Month Average Volume1,053,864

Chart

About Health Catalyst, Inc - Common stock (HCAT)

Health Catalyst Inc is a leading provider of data and analytics technology for healthcare organizations, focused on improving clinical and financial outcomes through its innovative solutions. By leveraging a robust data platform, the company enables healthcare providers to aggregate, analyze, and visualize their data, facilitating better decision-making and operational efficiencies. Health Catalyst's suite of applications and services supports organizations in their journey towards value-based care by enhancing performance improvement initiatives, driving better patient outcomes, and optimizing healthcare delivery systems. Ultimately, the company's mission is to empower healthcare organizations with the insights and tools needed to transform the industry and enhance the quality of care. Read More

News & Press Releases

Bentley Systems, Guidewire Software, Health Catalyst, and Doximity Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after software stocks rebounded as the market shook off growing uncertainty amid escalating tension in the Middle East. 
Via StockStory · March 2, 2026
Health Catalyst to Announce Fourth Quarter and Year End 2025 Operating Results and Host Conference Call on Thursday, March 12, 2026
SALT LAKE CITY, March 02, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its fourth quarter and year end 2025 operating results on Thursday, March 12, 2026, after market close. In conjunction, the company will host a conference call to review the results at 5:00 pm ET on the same day.
By Health Catalyst, Inc. · Via GlobeNewswire · March 2, 2026
3 Out-of-Favor Stocks We Find Risky
The past year hasn't been kind to the stocks featured in this article. Each has tumbled to their lowest points in 12 months, leaving investors to decide whether they're witnessing fire sales or falling knives.
Via StockStory · February 26, 2026
Zoom, Akamai Technologies, Health Catalyst, SentinelOne, and PubMatic Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after investor fears over artificial intelligence disrupting the software industry sparked a broad sell-off. The anxiety stemmed from the rapid adoption of new 'agentic AI' tools, which some investors believed could dismantle traditional Software-as-a-Service (SaaS) business models. This 'AI Panic' led to indiscriminate selling across the sector. The market move reflected growing concerns about the downside of the AI boom for established software companies.
Via StockStory · February 17, 2026
Health Catalyst and F5 Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after investors continued to distinguish between the winners and losers in the artificial intelligence boom, leading to a broad sell-off. 
Via StockStory · February 12, 2026
3 Cash-Burning Stocks Walking a Fine Line
While some companies burn cash to fuel expansion, others struggle to turn spending into sustainable growth. A high cash burn rate without a strong balance sheet can leave investors exposed to significant downside.
Via StockStory · February 11, 2026
3 of Wall Street’s Favorite Stocks We Approach with Caution
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.
Via StockStory · February 5, 2026
Why Health Catalyst (HCAT) Stock Is Trading Lower Today
Shares of healthcare data analytics company Health Catalyst (NASDAQ:HCAT) fell 8.4% in the afternoon session after fears of disruption from artificial intelligence spooked investors, leading to a broad-based sell-off. 
Via StockStory · February 3, 2026
Unpacking Q3 Earnings: CLEAR Secure (NYSE:YOU) In The Context Of Other Data Analytics Stocks
As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the data analytics industry, including CLEAR Secure (NYSE:YOU) and its peers.
Via StockStory · January 22, 2026
Health Catalyst, MongoDB, Asana, Domo, and RingCentral Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after reports of easing geopolitical tensions in Greenland boosted investor sentiment. 
Via StockStory · January 22, 2026
Q3 Earnings Highs And Lows: Health Catalyst (NASDAQ:HCAT) Vs The Rest Of The Data Analytics Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Health Catalyst (NASDAQ:HCAT) and the best and worst performers in the data analytics industry.
Via StockStory · January 18, 2026
Health Catalyst, Veeva Systems, 8x8, Amplitude, and DocuSign Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after tech stocks pulled back as reports surfaced that Chinese customs authorities blocked Nvidia's H200 AI chips, effectively halting their entry despite recent U.S. export approvals. 
Via StockStory · January 14, 2026
3 Russell 2000 Stocks Walking a Fine Line
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the resilience and financial flexibility of large-cap firms, making careful selection crucial.
Via StockStory · January 6, 2026
3 Value Stocks We Find Risky
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason – five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.
Via StockStory · January 5, 2026
3 Stocks Under $10 We’re Skeptical Of
Stocks under $10 pique our interest because they have room to grow (as well as the most affordable option contract premiums). That doesn’t mean they’re bargains though, and we urge investors to be careful as many have risky business models.
Via StockStory · December 30, 2025
3 Software Stocks Walking a Fine Line
Software is eating the world, and virtually no business is left untouched by it. Companies bringing it to life have been rewarded with high valuation multiples that make fundraising easier, but they have capped returns lately as the industry was flat over the past six months and trailed the S&P 500’s 13.3% gain.
Via StockStory · December 24, 2025
3 of Wall Street’s Favorite Stocks We Think Twice About
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.
Via StockStory · December 15, 2025
HubSpot, nCino, Rapid7, and Health Catalyst Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after investors grew increasingly concerned that the billions of dollars being invested into artificial intelligence may not generate sufficient profits. 
Via StockStory · December 15, 2025
Q3 Earnings Outperformers: Samsara (NYSE:IOT) And The Rest Of The Data Analytics Stocks
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how data analytics stocks fared in Q3, starting with Samsara (NYSE:IOT).
Via StockStory · December 8, 2025
Health Catalyst and Unity Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after renewed enthusiasm for Alphabet reinvigorated the artificial intelligence trade, propelling a market rebound heading into the Thanksgiving holiday. The Nasdaq index jumped 2.6% and the S&P 500 gained 1.6%, driven by a 5% rally in Alphabet following the announcement of its upgraded Gemini 3 AI model. This optimism spilled over into the broader tech sector, lifting shares of Broadcom, Micron, and Palantir significantly. The rally built on momentum from the previous trading session, sparked by the New York Fed president keeping the door open for a December interest rate cut.
Via StockStory · November 24, 2025
Health Catalyst and ON24 Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. 
Via StockStory · November 21, 2025
Unity, Wix, Upstart, Samsara, and Health Catalyst Shares Are Falling, What You Need To Know
A number of stocks fell in the afternoon session after markets faded the Nvidia rally in the morning session, as investors remained uncertain about future rate cuts. 
Via StockStory · November 20, 2025
Health Catalyst (HCAT): Buy, Sell, or Hold Post Q3 Earnings?
What a brutal six months it’s been for Health Catalyst. The stock has dropped 44.2% and now trades at $2.18, rattling many shareholders. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.
Via StockStory · November 18, 2025
5 Revealing Analyst Questions From Health Catalyst’s Q3 Earnings Call
Health Catalyst’s third quarter results were met with a positive market reaction as the company delivered revenue above Wall Street expectations despite flat year-over-year performance. Management attributed the quarter’s outcome to solid execution in the Technology segment, which saw continued demand for its applications, and progress in improving gross margins through cost controls and operational changes. CEO Dan Burton highlighted that new client additions and successful client case studies, such as Temple University Health System’s $7.5 million in savings, underscored the real-world impact of its solutions. Management also noted ongoing efforts to optimize the business through restructuring less profitable service contracts and a disciplined approach to capital allocation.
Via StockStory · November 17, 2025
Health Catalyst to Participate in Upcoming Investor Conferences
SALT LAKE CITY, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that members of senior management will participate in the following upcoming investor conferences:
By Health Catalyst, Inc. · Via GlobeNewswire · November 14, 2025